MAM
GHDX

Martingale Asset Management’s Genomic Health, Inc. GHDX Stock Holding History

Martingale Asset Management’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-8,409
Closed -$247K – 986
2013
Q4 		$247K Sell
8,409
-400
-5% -$12.7K 0.01% 926
2013
Q3 		$270K Sell
8,809
-6,904
-44% -$231K 0.01% 900
2013
Q2 		$499K Buy
+15,713
New +$516K 0.02% 744

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
ICM
IronBridge Capital Management Oakbrook Terrace, Illinois $1.65B AUM 18.98% 1-Year Est. Return

Martingale Asset Management's GHDX Position: Q1 2014 in Review

Martingale Asset Management sold out of Genomic Health, Inc. (GHDX) in Q1 2014, closing a stake of 8,409 shares — an estimated $247K sold.

Martingale Asset Management first reported a position in GHDX in Q2 2013 and held it in 3 quarters. The position peaked at $499K in Q2 2013. 101 funds tracked by Wall St. Rank hold GHDX as of Q1 2014.

  • Martingale Asset Management reported no remaining Genomic Health, Inc. position as of Q1 2014 after selling out during the quarter.
  • Martingale Asset Management sold 8,409 Genomic Health, Inc. shares in Q1 2014, an estimated $247K.
  • Martingale Asset Management first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 3 quarters.
  • Martingale Asset Management's Genomic Health, Inc. position peaked at $499K in Q2 2013.
  • 101 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q1 2014.

Based on Martingale Asset Management's 13F filing for Q1 2014, filed 14 May 2014.